文献速递多重用药老年综合评估老年慢病共病管理

LESS-CHRON工具去处方:招募数据及对药物治疗影响的结果

Deprescribing Through the LESS-CHRON Tool: Recruitment Data and Results of Impact on Pharmacological Treatment (LESS-CHRON Validation Project).
PubMed 文献 · J Am Geriatr Soc · 2025-12-30

应用LESS-CHRON标准识别960种潜在不适当用药,成功去处方542种,接受率56.46%,总体治疗负担降低10.73%,抗胆碱能负担显著降低(p<0.001)。主要障碍为临床决策(69.86%)和患者/家属拒绝(11.72%)。

要点

  • LESS-CHRON工具可有效识别去处方机会,降低用药负担和抗胆碱能负荷。
  • 住院机构患者去处方成功率显著高于门诊患者(p<0.05)。
  • 临床决策和患者/家属拒绝是去处方的主要障碍。

核心结论

  • LESS-CHRON工具有效识别去处方机会,降低用药负担和抗胆碱能负荷,住院机构患者去处方成功率更高,但临床判断和患者偏好仍是关键障碍。

研究设计与样本

  • 多中心准实验前后对照队列研究,分筛选、干预及纳入后3个月和6个月随访阶段,纳入门诊和住院机构两个队列。

主要发现

  • 识别960种潜在不适当用药,成功去处方542种(涉及345例患者),接受率56.46%,两队列间无显著差异。
  • 总体治疗负担降低10.73%(SD:10.68)。
  • 3个月后61例患者至少重新启用一种已去处方药物。
  • 平均去处方成功率87.10%,住院机构患者显著更高(p<0.05),抗胆碱能负担显著降低(p<0.001)。

关键数值与推荐

  • 主要障碍为临床决策(69.86%)和患者/家属拒绝(11.72%)。

临床怎么用

  • 在多重共病或复杂慢性病患者中可应用LESS-CHRON标准识别去处方机会,并关注临床决策和患者/家属拒绝等障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Deprescribing is a key strategy for optimizing therapeutic plans in multimorbid or complex chronic patients. Despite its long-standing use, further studies are needed to validate health outcomes and support its routine clinical integration. This project aims to assess the impact of applying LESS-CHRON criteria in terms of therapeutic and anticholinergic burden, as well as to describe potentially inappropriate medications (PIMs) more often involved in chronic treatments of patients with multimorbidity or those with complex health needs across two care settings: institutionalized and outpatients. METHODS: A quasi-experimental, multicenter, pre-post intervention cohort study was conducted in several phases (screening, intervention, and follow-up at 3 and 6 months after inclusion). The study included two cohorts: outpatients and institutionalized patients. The main variable was the percentage reduction in medication use. Additionally, the deprescribing success rate, reasons for non-acceptance (barriers to deprescribing), anticholinergic burden, and non-pharmacological variables were analyzed. RESULTS: Four hundred and sixty patients (229 outpatients, 231 institutionalized) with a mean age of 84.5 (SD: 7.9) years were included. Demographic, clinical, and pharmacological data were collected. Deprescribing opportunities were identified using the LESS-CHRON criteria, and recommendations were assessed by medical teams. Follow-up evaluations were conducted after 3 months. A total of 960 PIMs were identified, of which 542 medications were successfully deprescribed (345 patients), with an acceptance rate of 56.46%, showing no significant differences between cohorts. The overall therapeutic burden was reduced by 10.73% (SD: 10.68). The main barriers to deprescribing were clinical decisions (69.86%) and patient/family refusal (11.72%). After 3 months, at least one deprescribed drug was reintroduced in 61 patients. The mean deprescribing success rate was 87.10%, which was significantly higher in institutionalized patients (p < 0.05), and the anticholinergic burden was significantly reduced (p < 0.001). CONCLUSION: The LESS-CHRON tool effectively identified deprescribing opportunities, reducing both medication burden and anticholinergic load. Institutionalized patients had a higher deprescribing success rate. However, clinical judgment and patient preferences remain key barriers to successful implementation.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Carrión-Madroñal IM, Mejías-Trueba M, Gómez-Herrero D, et al. Deprescribing Through the LESS-CHRON Tool: Recruitment Data and Results of Impact on Pharmacological Treatment (LESS-CHRON Validation Project). J Am Geriatr Soc. 2025. PMID: 41467581. doi:10.1111/jgs.70269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。